Ramez Eskander
MD
Professor, Division of Gynecologic Oncology
👥Biography 个人简介
Ramez Eskander is a clinical investigator who has led key studies defining how molecular subclassification of endometrial cancer should inform treatment selection. He participated in the RUBY trial evaluating dostarlimab plus carboplatin-paclitaxel and the GOG3031/ENGOT-en9 trial with pembrolizumab, helping establish immunotherapy plus chemotherapy as first-line standard for advanced endometrial cancer. His research focuses on biomarker-driven therapy selection and the differential benefit of immunotherapy across POLE-ultramutated, MMR-deficient, and p53-mutant endometrial cancer populations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ramez Eskander 的研究动态
Follow Ramez Eskander's research updates
留下邮箱，当我们发布与 Ramez Eskander（UC San Diego Health / Moores Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment